openPR Logo
Press release

NAD Dependent Protein Deacetylase Sirtuin 1: Significant Pipeline Review for the First Half of 2017

Pharmaceutical Industry Research Reports - MRH

Pharmaceutical Industry Research Reports - MRH

The NAD dependent protein deacetylase Sirtuin 1 market is growing since key related pharmaceutical markets are dependent entirely over it. Looking into this opportunity, a new study has been included into the vast online repository of Market Research Hub (MRH), with title, ‘’ NAD Dependent Protein Deacetylase Sirtuin 1 (SIR2 Like Protein 1 or Sirtuin Type 1 or Regulatory Protein SIR2 Homolog 1 or SIRT1 or EC 3.5.1.) - Pipeline Review, H1 2017‘’. The report strives to contribute a precise analysis of the most profitable factors such as major drug profiles, leading companies and careful pipeline review data.

Request Free Sample Report:

Today, the NAD dependent protein deacetylase Sirtuin 1 is a medicine used by many patients of fatty liver disease, steatohepatitis, diabetes, pneumonia, COPD and several types of cancers. The study begins with a significant introduction, product overview together with the therapeutics development. In this section, the report also evaluates the useful products under development in terms of therapy area, indication, companies as well as the universities and institutes. Accordingly, the report offers vital facts about the preclinical and discovery stages within universities for the benefit of the buyer.

Another important part of the report describes major products from therapy areas for major diseases in oncology, gastrointestinal, metabolic disorders, central nervous system, and genetic disorders alongside the infectious and respiratory diseases which contains indications. Together, the study analyzes the other disorders such as nonalcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), type 2 diabetes, bacterial pneumonia, chronic myelocytic leukemia (CML, Chronic Myeloid Leukemia), chronic obstructive pulmonary disease (COPD), emphysema, Ewing sarcoma, pancreatic cancer, Parkinson's disease, peritonitis, solid tumor and spinocerebellar ataxia (SCA).

Make An Enquiry:

Additionally, the report analyzes drug profiles for the pipeline products which contains useful topics such as product description, licensing and collaboration data together with other new developments. Some of the popular drugs evaluated in this pipeline analysis are the SIRT1, JOT-104, JOT-105, resveratrol and SRT-3025. Such drug-wise data helps the reader to involve in premium research for creating better products.

The report reviews key players involved in the production of this powerful medicine and enlists all their major and minor projects. Some of the major companies involved in this report are NuSirt Biopharma, Bial - Portela and Ca SA, GlaxoSmithKline Plc and Jyant Technologies Inc. Thus, the study introspects all the huge companies and their strategies as well as research data to help new investors gain higher revenues.

Browse Full Report With TOC:

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Read Industry News At:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release NAD Dependent Protein Deacetylase Sirtuin 1: Significant Pipeline Review for the First Half of 2017 here

News-ID: 599447 • Views: 274

More Releases from Pharmaceutical Research Reports [MRH]

Pipeline Analysis on Phenylalanine 4 Hydroxylase Reviewed by Company, Profiled D …
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC - Pipeline Review, H1 2017”. This research study outlays comprehensive information on the Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration
Aminopeptidase N (Myeloid Plasma Membrane Glycoprotein CD13 or Alanyl Aminopepti …
According to the latest pipeline analysis, Aminopeptidase N (APN/CD13) acts as an exopeptidase and has been studied for decades. In recent years, it has been seen not only as a tumor-related target but also as a potential functional protein in various other physiological or pathological processes, such as analgesia, virus infection and inflammation. To elaborate further details on its global demand, a study titled “Aminopeptidase N (Myeloid Plasma Membrane Glycoprotein
Global Indoleamine 2, 3 Dioxygenase 1 Industry Vital Pipeline Review for the Fir …
The indoleamine 2, 3 Dioxygenase 1 or IDO1 market is developing since the cancer treatment sector relies heavily on its’ in-depth research and high-quality treatments. Looking into this huge potential, a new study has been added to the vast online repository of Market Research Hub (MRH), with the title ‘’Indoleamine 2, 3 Dioxygenase 1 (Indoleamine Pyrrole 2, 3 Dioxygenase 1 or IDO1 or EC - Pipeline Review, H1 2017‘’.
Prosthetic Joint Infections - Clinical Trials Rise Due to Higher Disease Inciden …
Market Research HUB's Pharmaceutical and Healthcare latest pipeline guide Prosthetic joint infections - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Prosthetic joint infections (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news

All 5 Releases

More Releases for MRH

Global Dystrophin Pharmaceuticals Industry Research Report - MRH
A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is titled “Global Dystrophin Market Research Report” which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview. The report anticipates that the sector for Pharmaceutical would rise at a positive CAGR during the period 2017-2022. Request For Free Sample -
Global VOD In Hospitality Industry Trends and Forecast Report- MRH Report (2017) …
MRH announced a 'Medical Equipment' related topic "VOD In Hospitality Report by Material, Application, and Geography-Global Forecast to 2021" is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe, and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Request For Free Sample Report: The report firstly introduced the VOD In Hospitality basics:
Global Neuromodulation Market Research Report 2016 - MRH
This report of MRH studies Neuromodulation in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacture. Request Free Sample Report: Area Covering Medtronic, Inc. (U.S.) Boston Scientific Corporation (U.S.) St. Jude Medical, Inc. (U.S.) Synapse Biomedical, Inc. (U.S.) Nevro Corporation (U.S.) Neurosigma, Inc. (U.S.) Neuropace, Inc. (U.S.). Neuronetics, Inc. (U.S.) Cyberonics, Inc. (U.S.) BioControl Medical (Israel) Market Segment by Regions,
Smokeless Tobacco in Germany, 2017 Report : MRH
Although Germany is the largest market for cigarettes in Western Europe it has one of the smallest smokeless tobacco markets. Smokeless tobacco currently accounts for only 1.2% of the whole tobacco market as consumers prefer traditional cigarettes and cigars. Nevertheless, the market is well established in Germany due to its proximity to Scandavian countries to the north but is not popular among young adults. In addition to this, new EU
Global Beef Market Research Report 2017 - MRH
MRH Report: The "Global Beef Market" Research Report 2017 is a professional and in-depth study on the current state of the Beef market. Annual estimates and forecasts are provided for the period 2016 through 2021. Also, a six-year historic analysis is provided for these markets. The global market for Beef is expected to reach about 232243 Million USD by 2021 from 237639 Million USD in 2016, registering a Compounded Annual
Global Billiards and Snooker Equipment Market Research Report 2017 - MRH
Market Research Hub announced the report on the retailing topic "Billiards and Snooker Equipment Market Research". Request a Free Sample Report: Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Billiards and Snooker Equipment in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Billiards and Snooker Equipment market competition by top manufacturers, with production, price, revenue (value)